Sign in
4

Changes in Ownership

Opus Genetics, Inc. Filed Acc 0001140361-19-004274

Chief Medical Officer acquired 2,375 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Benaim Ely · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2019-02-28 Exercise or conversion : show line 1 in the form +2,375 4,750 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-02-28 Exercise or conversion : show line 2 in the form Restricted Stock Units −2,375 4,750 D
Loading xslF345X03/form4.xml…